In children with hypertrophic cardiomyopathy, the risk of death or heart transplantation was greatest
for those who presented as infants or with inborn errors of metabolism or with mixed hypertrophic and dilated or restrictive cardiomyopathy. Risk stratification by subgroup of cardiomyopathy, by characteristics such as low weight, congestive heart failure or abnormal echocardiographic findings, and by the presence of multiple risk factors allows for more informed clinical decision-making and prognosis at the time of diagnosis. (Free registration required.)

Full Story:
The Lancet

Related Summaries